Reddy Bana Sai Krishna, Dhadwad Jagannath S, Modi Kunal, Roushan Kumar, Kulkarni Prabhanjan, Dash Chandan
Internal Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Cureus. 2024 Oct 18;16(10):e71816. doi: 10.7759/cureus.71816. eCollection 2024 Oct.
Refractory hypercalcemia of malignancy (RHOM) is a challenging and often life-threatening condition characterized by persistently high serum calcium levels despite standard treatments. It is commonly associated with malignancies such as squamous cell carcinoma (SCC) of the lung, breast cancer, and multiple myeloma. However, studies on head and neck cancers, including SCC of the oral cavity, suggest that hypercalcemia can occur but is relatively rare. We report a case of a 45-year-old male with SCC of the buccal mucosa who presented with severe, refractory hypercalcemia. Despite aggressive hydration, bisphosphonates, calcitonin therapy, and glucocorticoids, serum calcium levels remained elevated. The patient was subsequently treated with hemodialysis, but despite this intervention, his clinical status did not improve, ultimately leading to his mortality. This case highlights the challenges in managing RHOM and underscores the need for better therapeutic strategies. Timely recognition and innovative treatment approaches are crucial for improving patient outcomes in refractory cases of hypercalcemia of malignancy.
恶性肿瘤难治性高钙血症(RHOM)是一种具有挑战性且往往危及生命的病症,其特征是尽管进行了标准治疗,但血清钙水平持续居高不下。它通常与肺癌、乳腺癌和多发性骨髓瘤等恶性肿瘤相关。然而,包括口腔鳞状细胞癌(SCC)在内的头颈部癌症研究表明,高钙血症虽可发生,但相对罕见。我们报告一例45岁男性颊黏膜鳞状细胞癌患者,该患者出现严重的难治性高钙血症。尽管进行了积极的补液、双膦酸盐、降钙素治疗和糖皮质激素治疗,血清钙水平仍居高不下。该患者随后接受了血液透析治疗,但尽管采取了这一干预措施,其临床状况并未改善,最终导致死亡。该病例凸显了管理RHOM的挑战,并强调了需要更好的治疗策略。及时识别和创新治疗方法对于改善恶性肿瘤高钙血症难治性病例的患者预后至关重要。